PDP policy requirement for design verification data to be modified by FDA.

SIMPLIFIED PDP OUTLINE UNDER CONSIDERATION BY FDA as a complement to its comprehensive policy on product development protocols. The agency says it would like to retain the existing policy because it would be helpful to manufacturers less familiar with the premarket review process, such as new start-ups. However, it also wants to address complaints from some manufacturers that the comprehensive policy is too detailed and prescriptive, and to this end may develop a simplified format.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Medtech Insight